TCRX - Tscan Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - TCRX (1783328)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2023-12-18
TCRXBarberich Timothy JDirP - Purchase$4.89+29,147100,286+41%+$142,456
2023-12-14
TCRXKlencke BarbaraDirP - Purchase$5.08+5,00055,000+10%+$25,400
2023-06-02
TCRXBarberich Timothy JDirP - Purchase$2.63+37,88071,139+114%+$99,564
2023-05-31
TCRXLynx1 Capital Management LP10%S - Sale$2.52-25,40010,464,6000%-$63,953
M
2022-12-27
TCRXSilver Brian M.CFOP - Purchase$1.54+6,00032,885+22%+$9,217
2022-05-18
TCRXSouthwell David PCEOP - Purchase$3.59+25,000171,569+17%+$89,821
M
2022-05-10
TCRXBaker Bros. Advisors LPDir, 10%P - Purchase$1.88+1,359,7922,528,583+116%+$2,559,154

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top